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ABSTRACT 
In the field of drug delivery, pH-sensitive polymeric microparticles can be used to release 
therapeutic payloads slowly in extracellular conditions (pH 7.4) and faster in more acidic areas in 
vivo, such as sites of inflammation, tumors, or intracellular conditions.  Our group currently uses 
and is further developing the pH-sensitive polymer acetalated dextran (Ac-DEX), which is a 
biodegradable polymer with highly tunable degradation kinetics.  Ac-DEX has displayed 
enhanced delivery of vaccine and drug components to immune and other cells, making it an 
extremely desirable polymer for immune applications.  Currently, one of the degradation 
products of Ac-DEX is methanol, which may cause toxicity issues if applied at high 
concentrations with repeated doses.  Therefore, in this manuscript we report the first synthesis 
and characterization of an Ac-DEX analog which, instead of a methanol degradation product, has 
a much safer ethanol degradation product. We abbreviate this ethoxy acetal derivatized 
acetalated dextran polymer as Ace-DEX, with the ‘e’ to indicate an ethanol degradation product.  
Like Ac-DEX, Ace-DEX microparticles have tunable degradation rates at pH 5 (intracellular).  
These rates range from hours to several days and are controlled simply by reaction time.  Ace-
DEX microparticles also show minimal cytotoxicity compared to commonly-used poly(lactic-co-
glycolic acid) (PLGA) microparticles when incubated with macrophages. This study aims to 
enhance the biocompatibility of acetalated dextran-type polymers to allow their use in high 
volume clinical applications such as multiple dosing and tissue engineering. 
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INTRODUCTION 
Polymers which undergo dramatic property changes in response to environmental stimuli 
such as pH, temperature, magnetic fields, and electromagnetic radiation have recently been 
developed.
1
 Because these polymers can change shape and solubility in response to a stimulus, 
they have many biomedical applications in which controlled release of a therapeutic is desired, 
including drug delivery and tissue engineering.
2
 One of the most important avenues for 
controlled release is the exploitation of natural pH differences in vivo by using pH-sensitive 
polymers to fashion micro- and nanoparticle drug carriers.
3
 The potential for these drug-loaded, 
pH-sensitive polymeric nanoparticle carriers has been explored by various groups, including 
delivering therapeutics intracellularly via the pH-gradient in the endocytic pathway,
4,5
 delivering 
immunosuppressants to acidic sites of inflammation in the gastrointestinal tract,
6,7
 and delivering 
chemotherapeutic agents to the slightly acidic extracellular pH of tumors.
8,9
 It is therefore 
necessary to engineer a polymer that is relatively stable at the extracellular pH of 7.4 yet quickly 
degrades and thus releases its drug payload faster in the acidic environment in which the drug 
delivery is desired. Localized and controlled release of drug through pH-sensitive polymeric 
devices such as nanoparticles has the potential to increase efficacy of the encapsulated drug, 
reduce the possibility of its toxic side effects, and perhaps even lead to dose-sparing (i.e. 
requiring less drug).
10,11
 
Various acid-sensitive polymers have been reported in the literature and fashioned into 
nanoparticles, such as poly(ortho esters),
12,13
 and poly(β-amino) esters,14,15 and polyketals.16 One 
of the most promising examples of a pH-sensitive polymer is acetalated dextran (Ac-DEX). Ac-
DEX, which is simply the polysaccharide dextran modified with cyclic and methoxy acyclic 
acetal moieties, is a recently described biocompatible, biodegradable, and pH-sensitive 
polymer.
17
 The main advantage of Ac-DEX over other pH-sensitive biopolymers is that its 
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degradation rate is easily tunable through the reaction time used to synthesize the polymer.
18
 
Longer reaction times are under thermodynamic control and create Ac-DEX with high degrees of 
cyclic acetals which hydrolyze slowly; shorter reaction times are under kinetic control and create 
Ac-DEX with high degrees of acyclic methoxy acetals which hydrolyze quickly. By simply 
varying the reaction time, the acetal coverage and thus the degradation rate of Ac-DEX can be 
carefully controlled, ranging from minutes to months depending on the desired application.
18
 In 
contrast, commonly used polymers in drug delivery such as poly(lactic-co-glycolic acid) (PLGA) 
or other polyesters are not pH sensitive and have fixed degradation rates depending on the 
molecular weight, often on the order of months.
19
 Ac-DEX microparticles have been explored by 
our group in various applications requiring pH-sensitive release, including adjuvant-based 
vaccines,
20
  immunosuppressant delivery to phagocytic cells,
21
 and chemotherapeutic delivery to 
pulmonary cancer cells.
22
 
A limitation of Ac-DEX, however, is that one of its degradation products is methanol, 
along with the more innocuous products of dextran (a sugar) and acetone (a common metabolic 
byproduct).
17
 On one hand, these degradation products are pH-neutral, unlike acidic PLGA 
degradation byproducts which can alter the local pH.
23
 Unfortunately, methanol is well known to 
be toxic to humans because it is metabolized to formic acid and leads to subsequent metabolic 
acidosis, which can cause blindness, and in serious cases, death.
24
 It is important to note that 
there is little threat of methanol poisoning for a single dosage of Ac-DEX microparticles, since 
the amount of methanol released would likely be well under the maximum acceptable safe 
methanol dosage for humans of approximately 28 mg/kg as reported by Paine and Dayan.
17,25 
However, it is unclear if applications needing higher volumes of Ac-DEX such as electrospun 
tissue scaffolds or multiple, high-frequency dosing would result in unsafe levels of methanol 
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release. Regardless, eliminating methanol as a degradation product is a practical next step to 
enhance the biocompatibility of the Ac-DEX family of polymers for wider therapeutic 
microparticle, nanoparticle, and tissue engineering applications in the clinical setting. 
Thus, the goal of this study was to develop an Ac-DEX-like biopolymer which would 
degrade into the pH-neutral byproducts of dextran, acetone, and ethanol instead of methanol. 
Ethanol is a far less toxic alcohol than methanol and is a more ideal degradation product for in 
vivo applications. We call this analog polymer ethoxy acetal derivatized acetalated dextran (Ace-
DEX), with the extra “e” to indicate ethanol as a degradation product. Because Ace-DEX has a 
different chemical structure than Ac-DEX, the properties of Ace-DEX needed to be 
characterized and compared to Ac-DEX. After Ace-DEX was successfully synthesized, 
1
H-NMR 
was used to confirm the exclusive presence of the ethanol degradation product and to quantify 
the effects of reaction time on cyclic and acyclic acetal coverage. Then, the degradation 
properties of Ace-DEX microparticles were investigated, including their pH-sensitive 
degradation characteristics and the ability to tune degradation rate with reaction time. Finally, the 
biocompatibility of Ace-DEX microparticles was compared to Ac-DEX and commonly-used 
PLGA microparticles in vitro. 
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MATERIALS AND METHODS 
Materials. 
All materials were purchased from Sigma-Aldrich (St. Louis, MO) and used as received 
unless otherwise noted. 
Ace-DEX Synthesis. 
Lyophilized dextran (1 g, MW = 10,400) and pyridinium p-toluenesulfonate (0.0617 
mmol) were dissolved in anhydrous dimethyl sulfoxide (DMSO, 10 mL) and reacted with 2-
ethoxypropene (37 mmol, Waterstone, Carmel, IN) under nitrogen gas. At various predetermined 
timepoints (5, 10, 50, 110, 480 min), aliquots were withdrawn and quenched with triethylamine, 
precipitated with basic water (0.02% v/v triethylamine in water, pH 9), vacuum filtered, and 
lyophilized for two days. The products were purified by dissolving them in ethanol (200 proof) 
and centrifuging (5 min, 10,000 × g, Thermo Legend Micro 21). The supernatants were 
precipitated again in basic water and lyophilized for two days to yield Ace-DEX polymer (1.5 g), 
a powdery white solid. 
Ace-DEX NMR Analysis. 
To prepare for NMR analysis, Ace-DEX polymer was suspended in deuterium oxide and 
hydrolyzed with deuterium chloride. After two hours, a 300 MHz 
1
H-NMR (Bruker 300 
Ultrashield) was used to read the samples. The analysis provided a 
1
H-NMR spectrum of Ace-
DEX and allowed for the cyclic/acyclic acetal content to be measured. The hydrolysis of one 
cyclic acetal produces one acetone molecule, whereas the hydrolysis of one acyclic ethoxy acetal 
produces one acetone and one ethanol molecule. Using these peak integrations and those of the 
hydrogens on the glucose ring for standardization, the cyclic and acyclic acetal coverages per 
100 glucose units were determined. A more detailed description of NMR analysis for Ac-DEX 
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(which follows the same procedure) may be found in the Supporting Information of Bachelder et 
al.
17 
Microparticle Synthesis. 
Empty Ace-DEX microparticles were prepared with the single-emulsion technique 
(water/oil) as previously described with Ac-DEX.
21
 Briefly, 100 mg of Ace-DEX was dissolved 
in dichloromethane (DCM, 1 mL) and added to a 3% poly(vinyl alcohol) (PVA) in PBS (17 mL) 
solution. This two-phase mixture was homogenized for 30 s (IKA-25 Ultra Turrax Homogenizer, 
S25N-18G head, 18,000 RPM) and the emulsion was immediately poured into a spinning 
solution of 0.3% PVA (40 mL). After two hours of spinning to evaporate the solvent and allow 
for particle hardening, the mixture was centrifuged (5 min, 20,000 × g). The supernatant was 
discarded, and the resulting microparticle sediment was washed with basic water (pH 9) and 
centrifuged under the same conditions several times in order to remove excess PVA. Finally, the 
microparticles were suspended in water (pH 9) and lyophilized for two days to yield Ace-DEX 
microparticles, a fluffy white solid. 
For comparison in toxicity analysis, Ac-DEX microparticles were prepared with the same 
procedure as described above, except Ac-DEX was used in place of Ace-DEX. This Ac-DEX 
polymer (MW = 10k) was synthesized as previously described in Kauffman et al.
21
 PLGA 
microparticles were also prepared with the same procedure, except PLGA (lactide:glycolide 
85:15, MW = 50,000 – 75,000 g/mol) was used in place of Ace-DEX. 
Electrospun Fiber Synthesis. 
A solution of Ace-DEX in ethanol (0.5 mg/mL) was prepared. The solution was 
electrospun at a voltage of 30 kV and a flow rate of 2 mL/hr using a 21G needle and a needle-to-
collector distance of 20 cm. 
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Scanning Electron Microscopy. 
Ace-DEX microparticles were suspended in basic water (pH 9), and a small amount was 
placed on an SEM pin stub. The samples were allowed to air dry. Fibers collected on aluminum 
foil were stuck directly to the SEM pin stub using carbon tape. All of the samples were sputter-
coated with a layer of Pd/Au alloy, and imaged with a FEI NOVA NanoSEM 400. 
Ace-DEX Microparticle Degradation Analysis. 
Ace-DEX microparticles were suspended in triplicate in sodium acetate buffer (pH 5.0) 
or in PBS (pH 7.4) at 1.5 mg/mL. The samples were kept at 37°C on a shaker plate at 150 RPM. 
At various timepoints, aliquots (120 μL) were withdrawn and centrifuged (15,000 × g, 5 min). 
The supernatants were removed (90 μL) and stored at -20°C in a 96-well polystyrene plate. After 
the last timepoint, the supernatants were analyzed with a microplate reductometric bicinchoninic 
acid based assay (BCA) according to the manufacturer’s protocol (Protein Assay Kit; Pierce, 
Rockford, IN). The absorbance was measured at 562 nm with a plate reader (FlexStation 3 
Benchtop Multi-Mode Microplate Reader). This assay quantified the amount of the degradation 
product dextran in the supernatant over time, and a curve was fit to the data. The polymer 
degradation half life, t1/2, was defined to be the time at which 50% of the Ace-DEX particles had 
degraded. 
Cell Preparation and MTT Assay. 
Macrophages (RAW 264.7; ATCC, Manassas, VA) were grown and maintained 
according to the manufacturer’s guidelines. Media was made with fetal bovine serum (50 mL; 
Hyclone, Pittsburgh, PA), penicillin-streptomycin (5 mL; Fischer, Pittsburgh, PA), and 
Dulbecco’s Modified Eagle’s Medium (450 mL; Fischer, Pittsburgh, PA). Cells were maintained 
at 100% relative humidity, 37 °C, and 5% CO2. Macrophages were plated at a concentration of 1 
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× 10
5 
cells/mL in a 96-well plate. After 24 hours, the media in each well was replaced with 
media containing Ace-DEX microparticles, Ac-DEX microparticles, or PLGA microparticles 
ranging from  100 ng/mL to 1 mg/mL. 
After another 24 hours, the MTT assay was performed to determine cell viability. Briefly, 
the media in each well was replaced with fresh media (150 μL) and a solution of MTT in media 
(5 mg/mL, 20 μL). The plate was incubated for 4 hours until purple formazan crystals formed. 
Then, the supernatants were removed and isopropanol (200 μL) was added to dissolve the 
crystals. The plate was analyzed with a plate reader at an absorbance of 560 nm, and the 
background absorbance at 670 nm was subtracted. These values were compared to the control 
wells, which contained only media, to determine the cell viability. Other controls, such as wells 
with dead cells grown in the absence of media and blank wells, were analyzed as well.  
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RESULTS AND DISCUSSION 
Ace-DEX Polymer, Microparticle, and Fiber Synthesis. 
Ethoxy acetal derivatized acetalated dextran (Ace-DEX) polymer was synthesized via the 
reaction scheme shown in Figure 1A with reaction times varying from 5 minutes to 8 hours. 
From this polymer, microparticles and fibers were formed, as shown in Figures 1B and 1C, 
respectively. Microparticles had spherical morphology and appeared fairly polydisperse by 
inspection, with diameters ranging from several hundred nanometers to several microns. 
Meanwhile, the electrospun fibers had a ribbon-like morphology with a width of several microns. 
In all, there seemed to be little difference between Ace-DEX and its analog Ac-DEX in terms of 
physical appearance and processing ability. Both polymers are a powdery white solid, and both 
polymers demonstrate facile fabrication of microparticles and fibers. The Ace-DEX 
microparticles in Figure 1B are visually similar to comparably-made Ac-DEX microparticles. 
Our group recently explored the parameters to optimize Ac-DEX microparticles in terms of yield 
and encapsulation efficiency, including molecular weight, concentration, homogenization speed, 
and other factors.
21
 If desired, it would be straightforward to perform the same study on Ace-
DEX microparticles. We have also recently demonstrated that Ac-DEX fibers can be synthesized 
via electrospinning (data not shown). However, as discussed in the introduction, Ace-DEX 
would now be the preferred polymer to use in future tissue engineering applications because it 
eliminates the methanol degradation product of Ac-DEX. 
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Figure 1. A. Reaction scheme to synthesize ethoxy-derivatized acetalated dextran (Ace-DEX) 
polymer. B. Ace-DEX microparticles formed by the solvent evaporation method. C. Ace-DEX 
fibers formed by electrospinning. 
 
1
H-NMR was used to confirm that the Ace-DEX polymer contained acyclic ethoxy 
acetals as theorized by analyzing its degradation products for the presence of ethanol and 
acetone. As previously mentioned, cyclic acteals degrade into acetone, and acyclic ethoxy acetals 
degrade into ethanol and acetone. A representative 
1
H-NMR spectrum of Ace-DEX degradation 
products is shown in Figure 2. The spectrum has clear acetone (-CH3, 2.2 ppm, peak A) and 
ethanol (–CH3, 1.2 ppm, peak B) peaks, confirming that the original Ace-DEX polymer indeed 
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contained acyclic ethoxy acetals.  The analog Ac-DEX has instead been shown to contain acyclic 
methoxy acetals and to degrade into methanol and acetone.
18
 The methanol peak (3.3 ppm) is 
absent from the Ace-DEX degradation products NMR spectrum in Figure 2. 
 
 
Figure 2. Representative 
1
H-NMR spectrum of Ace-DEX degradation products (dextran, 
ethanol, and acetone) in DCl/D2O, with labels for the three important peaks: A = acetone –CH3 
peaks (6H, 2.2 ppm, integration = 5.35), and B = ethanol –CH3 peak (3H, 1.2 ppm, integration = 
1.58). The integrations were standardized for each glucose unit by C = two glucose ring 
hydrogens (2H, 4.0 ppm, integration ≡ 1.00).  
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Ace-DEX Acetal Content 
As described in the methods section, the integrations of the ethanol and acetone peaks in 
the 
1
H-NMR spectra may be used to determine the cyclic and acyclic acetal content of the Ace-
DEX polymers. Figure 3 describes how the reaction time used to synthesize Ace-DEX polymer 
can control acyclic and cyclic acetal coverage, respectively. Acetal content is measured in acetal 
groups per glucose unit in the dextran backbone. There is a negative, logarithmic relationship 
between reaction time and acyclic ethoxy acetal coverage. This result is expected; since acyclic 
acetals are formed under kinetic control, they are more favored at shorter reaction times. 
Conversely, there is a positive, logarithmic relationship between reaction time and cyclic acetal 
coverage; since cyclic acetals are formed under thermodynamic control, they are more favored at 
longer reaction times.  
 
. 
Figure 3: Acyclic and cyclic acetal content per glucose unit in Ace-DEX polymer as measured 
by 
1
H-NMR. 
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It is evident from Figure 3 that as the reaction progresses, acyclic acetal groups are 
replaced with cyclic acetal groups. Around 100 min, it appears as if a limit of 0.72 cyclic acetals 
per glucose unit is reached. The cyclic acetal coverage actually slightly decreases at 480 min, 
most likely due to small amounts of water contamination in the reaction vessel. For the analog 
Ac-DEX polymer, Broaders et al. found a similar relationship between cyclic and acyclic 
methoxy acetal groups and reaction time.
18
 In Ac-DEX, however, the natural maximum of 
approximately 1 cyclic acetal per glucose unit is indeed reached, but this occurs at a much longer 
reaction time of about 25 hours. When comparing comparable reaction times between Ac-DEX 
(from Broaders’ paper18) and Ace-DEX, Ac-DEX appears to have a slightly higher degree of 
substitution for cyclic acetals, yet Ace-DEX has a higher degree of substitution of acyclic 
acetals. Because cyclic acetals replace acyclic acetals over time, this difference in acetal degree 
of substitution indicates that the Ace-DEX reaction is slower than the Ac-DEX reaction. It is 
hypothesized that the extra methyl group on the reactant 2-ethoxypropene causes minor steric 
hindrance and thus a reduced reaction rate.  Understanding the relationship between acetal 
coverage and reaction time is important because the cyclic acetal content is the key factor in Ac-
DEX-type polymer degradation,
18
 and this phenomenon is also explored for Ace-DEX in the 
next section. 
 
Ace-DEX Microparticle Degradation 
Cyclic acetal content has been found to control the degradation rate of Ac-DEX 
micro/nanoparticles.  Broaders et al. theorized that because cyclic acetal groups are formed under 
thermodynamic control (i.e. longer reaction times), the reverse reaction of acetal hydrolysis also 
occurs more slowly on Ac-DEX polymers with high degrees of cyclic acetalization; similarly, 
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acyclic acetal groups are formed under kinetic control (i.e. shorter reaction times), so they 
undergo faster hydrolysis and lead to faster degrading polymer.
18
 Although it was expected that 
Ace-DEX would behave similarly to Ac-DEX in terms of degradation, it was possible that the 
extra methyl group on acyclic ethoxy acetal groups of Ace-DEX and its increased 
hydrophobicity could lead to steric hindrance of hydrolysis or alter the rate of degradation.  
To understand the degradation characteristics of Ace-DEX, microparticles synthesized from 
varying reaction times using the solvent evaporation technique (shown in Figure 1B) were 
degraded in a pH 5 buffer. This acidic buffer represents an important physiological pH: it models 
both the phagosomal conditions of macrophages and dendritic cells for immunotherapy 
applications as well as sites of inflammation. It is advantageous to fashion micro/nanoparticles 
from an acid-sensitive polymer for these applications in order to localize the release of the 
encapsulated drug to the desired acidic pH region rather than physiological pH-neutral 
conditions, thereby minimizing side effects and maximizing efficiency.  
Figure 4 shows the degradation profiles of three sets of Ace-DEX microparticles synthesized 
with varying reaction times in a pH 5 buffer. In general, increasing the reaction times lengthens 
the time required for the microparticles to fully degrade. This trend is consistent with reports for 
Ac-DEX; the degradation profile for Ace-DEX from Figure 4 and that of Ac-DEX reported by 
Broaders et al. were quantitatively similar,
18
 which will be discussed in detail later. It is clear 
from Figure 4 that the degradation of Ace-DEX microparticles is quite tunable and can be 
controlled simply by varying the reaction time. The fastest degrading particle set (fashioned from 
5 min Ace-DEX) fully degraded in approximately one hour in a burst fashion, whereas the 
slowest degrading particle set (made from 480 min Ace-DEX) required approximately a week to 
fully degrade and offered a more linear degradation profile. This wide range of degradation rates 
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in acidic conditions means that the degradation of Ace-DEX particles and thus release of the 
encapsulated drug could be tailored to specific applications. It is theorized that even longer 
degradation times could be achieved by increasing the molecular weight of the polymer; it has 
been shown that increasing the molecular weight for Ac-DEX from 10k to 71k lengthened the 
overall degradation rate approximately three-fold in pH 5 buffer.
21
 Higher cyclic acetal 
coverages and thus longer-degrading particles might also be obtained by using a more 
sophisticated reaction vessel which guarantees anhydrous conditions; as was discussed in the 
previous section, it is unclear if the limit of approximately 0.72 cyclic acetals per glucose unit on 
Ace-DEX was due to kinetics or slight water contamination and partial hydrolysis. 
 
 
Figure 4: Degradation profiles of microparticles fashioned from 5 min, 50 min, and 480 min 
Ace-DEX in a pH 5 buffer.  
 
In Figures 5A-C, the Ace-DEX microparticles were found to have a much slower, more 
linear degradation in pH 7.4 buffer (physiological conditions) than pH 5. With the exception of 5 
min Ace-DEX particles, all other Ace-DEX particles were less than 10% degraded in pH 7.4 at 
the time of complete degradation in pH 5 buffer. Visually, the difference in degradation in acidic 
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and pH-neutral conditions was easy to see; as time goes on, the suspension of microparticles in 
pH 5 buffer went from cloudy to completely colorless, whereas the suspension of microparticles 
in pH 7.4 buffer stayed cloudy during the duration of the experiment. Ace-DEX microparticles 
are therefore well-suited to be tailored for use in a variety of drug delivery applications requiring 
acid-sensitive degradation, ranging from those which require a quick burst of the encapsulated 
drug to those which require a controlled, sustained release of drug. Furthermore, Ace-DEX 
particles may be advantageous to use in place of Ac-DEX particles for frequent and high-
concentration dosing applications because Ace-DEX degrades into ethanol instead of methanol. 
 
 
Figure 5: A. Comparison of 5 min Ace-DEX microparticle degradation in pH 5 and pH 7.4. B. 
Comparison of 50 min Ace-DEX microparticle degradation in pH 5 and pH 7.4. C. Comparison 
of 480 min Ace-DEX microparticle degradation in pH 5 and pH 7.4. Data is presented as mean ± 
standard deviation, n = 3. 
 
A second way to quantify Ace-DEX microparticle degradation is by investigating their 
degradation half lives (t1/2, the time required for 50% of the microparticle to degrade in pH 5 
buffer). Half lives are plotted against reaction time, acyclic acetal coverage, and cyclic acetal 
coverage in Figure 6. Figures 6A and 6B show that half lives are directly correlated to reaction 
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time and inversely correlated to acyclic acetal coverage. Figure 6C, on the other hand, suggests 
that as Ace-DEX cyclic acetal coverage increases, the half life also increases. 
 
 
Figure 6. Degradation half lives (t1/2) of Ace-DEX microparticles in pH 5 buffer plotted against 
A. reaction time, B. acyclic acetal coverage, and C. cyclic acetal coverage. 
 
Comparison of Ace-DEX and Ac-DEX Microparticle Degradation 
The degradation of Ac-DEX
18
 is quantitatively and qualitatively similar to the 
degradation of Ace-DEX (Figure 4) even though equivalent polymer reaction times lead to 
higher cyclic acetal coverage with Ace-DEX (Figure 3).  Generally, the time required to fully 
degrade the microparticles is relatively similar for both Ac-DEX and Ace-DEX microparticles 
formulated from polymer with the same reaction time.  Based on the kinetics of degradation 
presented in Figure 5, the rate of degradation differs somewhat between the two polymers.  
Polymers with low t1/2 but longer overall degradation times have an initial burst degradation.  
Since acyclic acetals hydrolyze faster than cyclic acetals, they are primarily responsible for burst 
degradation.  Thus, if the extra methyl group significantly slowed degradation on acyclic ethoxy 
acetal groups of Ace-DEX, we would observe a decreased burst (i.e. longer t1/2) with Ace-DEX 
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compared to Ac-DEX synthesized under the same reaction time.  When comparing our Ace-DEX 
half-life data to the Ac-DEX half-life data published by Broaders et al.,
18
 there is indeed a longer 
t1/2 and thus less pronounced burst with Ace-DEX than Ac-DEX.  Based on these degradation 
kinetics, Ace-DEX microparticles may offer a more sustained release of the encapsulated 
therapeutic entity as compared to similar Ac-DEX microparticles. 
 
Effects of Molecular Weight on Ace-DEX 
 It has been previously shown that the molecular weight of the polymer is an important 
factor in Ac-DEX microparticle degradation: increasing the molecular weight of Ac-DEX from 
10k to 71k lengthened the overall degradation rate by approximately threefold.
21
 Varying the 
molecular weight further increases the tunability and versatility of the Ac-DEX polymer. In 
addition, it was found that increasing the molecular weight of Ac-DEX also had the benefits of 
higher drug encapsulation efficiency and better particle yield.
21
 The authors speculated that the 
improved encapsulation efficiency was likely caused by the increased viscosity of the higher 
molecular weight polymer and its lower solubility in the solvent, allowing less drug to diffuse 
out during microparticle solidification; additionally, the increased chain length of 71k Ac-DEX 
could have made entrapment of the drug easier.
21 
 71k Ace-DEX was synthesized using the same procedure as 10k Ace-DEX, except 71k 
dextran was used as the polymer backbone. 71k Ace-DEX microparticles were fashioned with 
the goal of observing the same lengthened rates as Ac-DEX, and the degradation of these Ace-
DEX microparticles in pH 5 buffer is quantified in Figure 7 below. Interestingly, Figure 7 (data 
with 71k Ace-DEX) is not significantly different than Figure 4 (data with 10k Ace-DEX 
microparticles). In fact, 480-min 71k Ace-DEX microparticles actually appear to degrade faster 
 18  
 
than 10k Ace-DEX microparticles. For Ace-DEX, the molecular weight does not appear to play a 
significant role in the microparticle degradation kinetics, which is in direct contrast to Ac-DEX. 
 
 
Figure 7: Degradation profiles of microparticles fashioned from 5 min, 50 min, and 480 min 71k 
Ace-DEX (higher molecular weight) in a pH 5 buffer. 
 
 The degradation profiles in Figure 7 did not match expected results and were in direct 
contradiction of established data for the analog polymer Ac-DEX. As was done with 10k Ace-
DEX microparticles, the half lives (t1/2) of 71k Ace-DEX microparticles in pH 5 buffer were 
plotted versus cyclic acetal coverage in Figure 8A. Figure 8A reveals another odd trend for 71k 
Ace-DEX microparticles: four different reaction times appear to have similar cyclic coverages of 
around 1.0, but they have vastly different degradation half lives, ranging from about 15 to 30 
hours. This again is direct contrast to both Ac-DEX and 10k Ace-DEX, for which cyclic acetal 
coverage is primarily responsible for controlling the degradation kinetics.  
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 In an effort to explain these strange results, we hypothesized that acetals groups may be 
cross-linking in 71k Ace-DEX, as shown in Figure 8B. Since 71k Ace-DEX has a longer 
polymer chain length than 10k, forming cross-linked acetals is statistically more probable. Cross-
linked acetals would degrade into the same byproducts as cyclic acetals, so they would be 
wrongly “counted” as cyclic acetals by the NMR analysis; but cross-linked acetals may have 
markedly different degradation properties than cyclic acetals, which could potentially explain the 
strange degradation kinetics shown for 71k Ace-DEX microparticles in Figures 7 and 8A.  
 
 
Figure 8: A. Plot of half lives (t1/2) versus cyclic coverage for 71k Ace-DEX microparticles in 
pH 5 buffer. B. Schematic of proposed cross-linking acetals (top) versus traditional cyclic acetals 
(bottom) in 71k Ace-DEX polymer. 
 
 In an attempt to determine if cross-linking was occurring, Gel Permeation 
Chromatography (GPC) (courtesy of Dr. Dennis Bong) was performed on four 71k Ace-DEX 
polymer samples of varying reaction times. Unfortunately, the resultant GPC peaks were too 
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wide to be properly integrated. Ace-DEX is a biopolymer, meaning it is very polydisperse to 
begin with. A large, wide peak was observed over a wide range of retention times for all four 
samples, and the four samples were indistinguishable from each other. Therefore, GPC analysis 
was inconclusive regarding the existence of cross-linked acetal groups. 
 In summary, no conclusions about the effects of molecular weight on Ace-DEX polymer 
can be made. Higher molecular weight 71k Ace-DEX microparticles did not have lengthened 
degradation rates (Figure 7) and the degradation kinetics did not appear to be significantly 
correlated with cyclic acetal coverage (Figure 8A); both of these trends do not agree with the 
established trends of Ac-DEX, and GPC testing could not determine if cross-linking was 
occurring, which could have potentially explained these inconsistencies. Therefore, more 
experimentation is needed in this area to determine the true effects of molecular weight on the 
behavior of Ace-DEX polymer and its microparticles.  
 
In Vitro Toxicity Analysis of Ace-DEX Microparticles 
Finally, the 10k Ace-DEX microparticles were incubated with RAW macrophages and 
the cell viabilities after 24 hours were determined, as shown in Figure 9. Poly(lactic-co-glycolic 
acid) (PLGA) was used as a control in this study, since it is one of the most commonly used 
polymers in drug delivery applications and is FDA-approved.
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 Ac-DEX polymer has also 
previously been shown to be as biocompatible as PLGA with HeLa cells at concentrations 
ranging from 1 μg/mL to 10 mg/mL.17 As expected, there was more cell death at higher 
concentrations of particles (Figure 9). At all microparticle concentrations, there was no 
significant difference between cell viabilities when incubated with Ace-DEX, PLGA, or Ac-
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DEX microparticles. This study validates that microparticles fashioned from Ace-DEX polymer 
are biocompatible and may be used in future in vitro and in vivo studies. 
 
 
Figure 9: Cell viabilities of RAW macrophages at varying 10k Ace-DEX, 10k Ac-DEX, and 
PLGA microparticle concentrations after 24 hours of incubation by MTT assay. Data is 
presented as mean ± standard deviation, n = 3. 
 
  
 22  
 
CONCLUSIONS 
In conclusion, we have shown the first synthesis and characterization of ethoxy acetal 
derivatized acetalated dextran (Ace-DEX) polymer and microparticles which degrade into 
ethanol, acetone, and dextran. Like its Ac-DEX analog, Ace-DEX is a pH-sensitive polymer, 
degrading more quickly in pH 5 conditions than pH 7.4 conditions. Unlike commonly used 
polyesters such as PLGA, Ace-DEX exhibits remarkable degradation rate tunability in acidic 
conditions. We have shown that Ace-DEX microparticles can fully degrade during time scales 
ranging from approximately one hour to one week simply by varying the reaction time to 
synthesize the polymer. Finally, Ace-DEX microparticles exhibit comparable cytotoxicity to 
macrophage cells as FDA-approved PLGA. No conclusions can yet be made on the effects of 
molecular weight on Ace-DEX polymer and microparticles. On the whole, Ace-DEX shares 
many properties (such as powder appearance, processing ability, degradation rates) as the more 
fully-studied analog Ac-DEX; it appears that Ace-DEX microparticles have less of a burst 
degradation than Ac-DEX microparticles but approximately the same overall degradation time. It 
should therefore be straightforward to substitute Ace-DEX for Ac-DEX polymer, the latter of 
which has been investigated for use in wide-ranging therapeutic applications requiring acid-
sensitive microparticle degradation, including vaccines, chemotherapy, and immunotherapy. 
Furthermore, since we have replaced the methanol degradation product with a far safer ethanol 
degradation product, Ace-DEX polymer has tremendous potential for use in high volume 
therapeutic applications, such as multiple dosing and tissue engineering, which we intend to 
explore in future work.  
  
 23  
 
REFERENCES 
1. Hoffman, A. S.; Stayton, P. S.; Bulmus, B.; Chen, G.; Chen, J.; al., e., Really Smart 
Bioconjugates of Smart Polymers and Receptor Proteins. J. Biomed. Mater. Res. 2000, 52, 577-
586. 
2. Gutowska, A.; Jeong, B., Lesson From Nature: Stimuli-Responsive Polymers And Their 
Biomedical Applications. Trends Biotechnol. 2002, 20, 305-311. 
3. Gao, W.; Chan, J. M.; Farokhzad, O. C., pH-Responsive Nanoparticles for Drug 
Delivery. Mol. Pharm. 2010, 7, 1913-1920. 
4. Hu, Y.; Litwin, T.; Nagaraja, A. R.; Kwong, B.; Katz, J.; Watson, N.; Irvine, D. J., 
Cytosolic Delivery of Membrane-Impermeable Molecules in Dendritic Cells Using pH-
Responsive Core-Shell Nanoparticles. Nano Lett. 2007, 7, 2056-3064. 
5. Mellman, I.; Fuchs, R.; Helenius, A., Acidification of the Endocytic And Exocytic 
Pathways. Ann. Rev. Biochem. 1986, 55, 663-700. 
6. Lamprecht, A.; Yamamoto, H.; Takeuchi, H.; Kawashima, Y., A pH-Sensitive 
Microsphere System for the Colon Delivery of Tacrolimus Containing Nanoparticles. J. Control. 
Release 2005, 104, 337-346. 
7. Makhlof, A.; Tozuka, Y.; Takeuchi, H., A pH-Sensitive Nanosphere for Colon-Specific 
Drug Delivery in Experimentally Induced Colitis Rat Model. Eur. J. Pharm. Biopharm. 2009, 
72, 1-8. 
8. Lee, E. S.; Gao, Z.; Bae, Y. H., Recent Progress in Tumor pH Targeting Nanotechnology. 
J. Control. Release 2008, 132, 164-170. 
9. Engin, K.; Leeper, D. B.; Cater, J. R.; Thistlethwaite, A. J.; Tupchong, L.; McFarlane, J. 
D., Extracellular pH Distribution in Human Tumours. Int. J. Hypertherm. 1995, 11, 211-216. 
 24  
 
10. Davis, M. E.; Chen, Z.; Shin, D. M., Nanoparticle Therapeutics: An Emerging Treatment 
Modality for Cancer. Nat. Rev. Drug Discov. 2008, 7, 771-782. 
11. Dhar, S.; Kolishetti, N.; Lippard, S. J.; Farokhzad, O. C., Targeted Delivery of a Cisplatin 
Prodrug for Safer And More Effective Prostate Cancer Therapy In Vivo. Proc. Nat. Acad. Sci. 
2011, 108, 1850-1855. 
12. Heller, J.; Barr, J.; Ng, S. Y.; Abdellauoi, K. S.; Gurny, R., Poly(ortho esters): Synthesis, 
Characterization, Properties, and Uses. Adv. Drug Deliv. Rev. 2002, 54, 1015-1039. 
13. Wang, C.; Ge, Q.; Ting, D.; Nguyen, D.; Shen, H.; Chen, J.; Eisen, H. N.; Heller, J.; 
Langer, R.; Putnam, D., Molecularly Engineered Poly(ortho ester) Microspheres for Enhanced 
Delivery of DNA Vaccines. Nat. Mater. 2004, 3, 190-196. 
14. Lynn, D. M.; Langer, R., Degradable Poly(β-amino Esters): Synthesis, Characterization, 
and Self-Assembly with Plasmid DNA. J. Am. Chem. Soc. 2000, 122, 10761-10768. 
15. Little, S. R.; Lynn, D. M.; Puram, S. V.; Langer, R., Formulation and Characterization of 
Poly(β Amino Ester) Microparticles for Genetic Vaccine Delivery. J. Control. Release 2005, 
107, 449-462. 
16. Heffernan, M. J.; Murthy, N., Polyketal Nanoparticles: A New pH Sensitive 
Biodegradable Drug Delivery Vehicle. Bioconjugate Chem. 2005, 16, 1340-1342. 
17. Bachelder, E. M.; Beaudette, T. T.; Broaders, K. E.; Dashe, J.; Frechet, J. M., Acetal-
derivatized Dextran: an Acid-responsive Biodegradable Material for Therapeutic Applications. J. 
Am. Chem. Soc. 2008, 130, 10494-10495. 
18. Broaders, K. E.; Cohen, J. A.; Beaudette, T. T.; Bachelder, E. M.; Frechet, J. M., 
Acetalated Dextran is a Chemically and Biologically Tunable Material for Particulate 
Immunotherpay. Proc. Nat. Acad. Sci. 2009, 106, 5497-5502. 
 25  
 
19. Anderson, J. M.; Shive, M. S., Biodegradation and Biocompatibility of PLA and PLGA 
Microspheres. Adv. Drug Deliv. Rev. 1999, 28, 5-24. 
20. Bachelder, E. M.; Beaudette, T. T.; Broaders, K. E.; Frechet, J. M.; Albrecht, M. T.; 
Mateczun, A. J.; Ainslie, K. M.; Pesce, J. T.; Keane-Myers, A. M., In Vitro Analysis of 
Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants. Mol. 
Pharm. 2010, 7, 826-835. 
21. Kauffman, K. J.; Kanthamneni, N.; Meenach, S. A.; Pierson, B. C.; Bachelder, E. M.; 
Ainslie, K. M., Optimization of Rapamycin-loaded Acetalated Dextran Microparticles for 
Immunosuppresion. Int. J. Pharm. 2012, 422, 356-363. 
22. Meenach, S. A.; Kim, Y. J.; Kauffman, K. J.; Kanthamneni, N.; Bachelder, E. M.; 
Ainslie, K. M., Synthesis, Optimization, and Characterization of Camptothecin-loaded 
Acetalated Dextran Porous Microparticles for Pulmonary Delivery. Mol. Pharm. 2012, 9, 290-
298. 
23. Lu, L.; Peter, S. J.; Lyman, M. D.; Lai, H. L.; Leite, S. M.; Tamada, J. A.; Uyama, S.; 
Vacanti, J. P.; Langer, R.; Mikos, A. G., In Vitro and In Vivo Degradation of Porous Poly(DL-
lactic-co-glycolic acid) Foams. Biomaterials 2000, 21, 1837-1845. 
24. Tephly, T. R., The Toxicity of Methanol. Life Sci. 1991, 48, 1031-1041. 
25. Paine, A. J.; Dayan, A. D., Defining a Tolerable Concentration of Methanol in Alcoholic 
Drinks. Hum. Exp. Toxicol. 2001, 20, 563-568. 
26. Lu, J. M.; Wang, X.; Marin-Muller, C.; Wang, H.; Lin, P. H.; Yao, Q.; Chen, C., Current 
advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev. Mol. 
Diagn. 2009, 9, 325-341. 
 
